Nexalin Technology, Inc. Common Stock NXL
Key Stats
- Today's Range
- $5.15 – $5.88
- 50-Day Range
- $4.00 – $15.01
- 52-Week Range
- $4.00 – $60.00
- Volume
- 1.22 million shs
- Average Volume
- 2.13 million shs
- Market Cap
- $6.26 million
- P/E Ratio
- —
- Dividend Yield
- 22.12%
Dividend
- Dividend Yield
- 22.12%
- Annual Dividend
- $1.25
- Payout Ratio
- —
- Ex-Dividend Date
- 2007-03-23
Short Interest
- Short Interest
- 2.34%
- Days to Cover
- 1.00
About Nexalin Technology, Inc. Common Stock
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Related Stocks
Compare head-to-head: NXL vs MDT·NXL vs AXGN·NXL vs BLFS·NXL vs CNMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.